Browse by category

D&D Pharmatech has completed patient enrolment in DD01-DN-2, an ongoing Phase 2 trial designed to evaluate the efficacy and safety of...

Helix has launched a new comprehensive clinico-genomic dataset of over 15,000 patients treated with glucagon-like-peptide-1 (GLP-1)...

Micronutrient deficiencies are common in people with type 2 diabetes, according to the findings of a pooled data analysis of the...

TNF Pharmaceuticals has initiated the first in a series of studies to evaluate the impact of its novel oral TNF-alpha (TNF-α) inhibitor...

Napo Pharmaceuticals has filed a broad defining provisional patent application with the US Patent and Trademark Office (USPTO) for...

In patients with type 2 diabetes, Roux-en-Y gastric bypass and sleeve gastrectomy for weight loss may be effective for reducing long-term...

The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease) and death due to...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Patients with obesity and fatty liver-related cirrhosis who had bariatric surgery significantly lowered their future risk of developing...

The Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the Quality Team at North...